SCHOOL OF CHINESE MEDICINE
Hong Kong Baptist University (HKBU) has taken a strategic approach to the research and development of drugs based on traditional Chinese Herbal Medicine (CHM) with the establishment of the Centre for Chinese Herbal Medicine Drug Development in the Health@InnoHK cluster (The Centre).
For years, the University has been focusing on the translation of Chinese medicinal wisdom into pharmaceutical products using cutting-edge technology. The Centre will serve as a strategic platform for HKBU researchers to join forces with renowned global partners and expand the range of CHM-based drugs. It will achieve this goal by enhancing the quality of preclinical and clinical CHM research and transforming the results into pharmaceutical products for international markets.
The Centre has three main objectives:
Creating a platform for the development of CHM-based drugs, including the functional units of preclinical and clinical studies, such as pharmacognosy, pharmacology, toxicology, pharmacokinetics/pharmacodynamics, omics and bioinformatics;
Developing new CHM-based drugs to fill the gaps in the market; and
Nurturing talent for CHM research in Hong Kong.
Centre for Chinese Herbal Medicine Drug Development
Assistant Director (Research and Development) (PR0114/20-21)
Reporting to the Centre Director, the appointee should be an integrative and collaborative leader who is responsible for the formulation and implementation of strategic plans and the new drug development programmes.
To oversee the progress of new drug development and investigational new drug (IND) application locally and globally;
To formulate and implement policies and procedures for drug development;
To collaborate with cross-functional teams to identify, prioritize, and oversee the execution of good clinical practice (GCP), good laboratory practice (GLP), and good manufacturing practice (GMP) processes;
To design, implement and manage the risk-based Quality Systems to comply with regulations of GCP, GLP and GMP;
To manage routine audit conducted by external consultants;
To collaborate with supported functions to develop and implement inspection readiness plans;
To oversee quality control and promote compliance awareness throughout the Centre; and
To undertake any other duties as assigned.
A postgraduate degree or above in a discipline related to medicine or allied health;
At least 10 years of experience in pharmaceutical or biopharmaceutical research and/or in relevant industry. Knowledge of drug research and drug development will be advantageous;
Competency in new drug application and registration locally and globally, such as China’s National Medical Products Administration, the United States Food and Drug Administration, etc.;
Experience in leading and executing the risk-based quality and compliance strategies;
An excellent command of written and spoken English and Chinese (Cantonese and Putonghua);
Strong ability to prioritize and operate with a sense of urgency;
Effective communication and interpersonal skills, including the ability to interact with all levels of the Centre;
Exhibits integrity and commitment to high ethical and compliance standards; and
Capable of working independently and being an effective leader.
Shortlisted candidates will be invited to attend a written assessment.
Those who have responded to the previous advertisement need not re-apply.
Initial appointment will be offered on a fixed-term contract of two years. Re-appointment thereafter will be subject to mutual agreement and availability of funding.
Salary will be commensurate with qualifications and experience.
Applicants are invited to submit their applications at the HKBU e-Recruitment System (jobs.hkbu.edu.hk). Those not invited for interview 4 months after the closing date may consider their applications unsuccessful. Details of the University’s Personal Information Collection Statement can be found at http://pers.hkbu.edu.hk/pics.
The University reserves the right not to make an appointment for the post advertised, and the appointment will be made according to the terms and conditions then applicable at the time of offer.
Closing date: Review of applications will begin immediately and will continue until the position is filled.